Latest developments in causes and treatments



Month: June 2024

The Anticipation Wrinkle

Today, dopamine seems to be universally regarded as “the reward.” But the dopamine/eating link is also a two-way street.

Why Isn’t Big Pharma Investing in GLP-1 Trials for Substance Use Disorders?

There’s a noticeable lack of pharmaceutical company trials of GLP-1 drugs as treatments for substance use disorders.

Does Ozempic Cause Weight Loss by Impacting the Brain or the Gut?

A study from The Netherlands examines the impacts of GLP-1 agonists on the central nervous system using fMRI.

Is Ozempic the Gateway Drug for CBT?

Two recent studies show nearly twice the weight loss for patients who undergo group CBT in addition to taking liraglutide, a GLP-1 agonist.

Social Media Addiction Cases Dismissed Against Meta, Snap, TikTok, and Google

A California state judge dismissed school district claims that tech companies be held liable for social media addiction.

A Pathway Out of Addiction?

Could a wearable ultrasound device be a pathway out of addiction, or even a way to prevent it?